China Pharma Holdings (CPHI) Raw Materials (2017 - 2024)
China Pharma Holdings' (CPHI) quarterly Raw Materials came in at $869820.0 in Q3 2024, down 53.69% YoY from $1.9 million in Q4 2023, and down 27.15% on a QoQ basis from $1.2 million in Q2 2024.
China Pharma Holdings (CPHI) Raw Materials (2017 - 2024) Analysis & Trends
China Pharma Holdings (CPHI) has 8 years of Raw Materials data on file, last reported at $869820.0 in Q3 2024.
- Quarterly Raw Materials fell 53.69% year-over-year to $869820.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $869820.0 (down 53.69% YoY) and the FY2023 annual result came in at $1.8 million, up 0.52% from the prior year.
- Raw Materials slipped to $869820.0 in Q3 2024, from $1.2 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $2.2 million in Q1 2023 to a low of $869820.0 in Q3 2024.
- A 5-year average of $1.8 million and a median of $1.8 million in 2021 frame the typical range for Raw Materials.
- Annual changes were most pronounced in 2023 — Raw Materials advanced 20.5% — and 2024, when it slumped 53.69%.
- Tracing CPHI's Raw Materials over 5 years: stood at $2.1 million in 2020, then dropped by 11.63% to $1.8 million in 2021, then changed by 0.0% to $1.8 million in 2022, then gained by 0.52% to $1.8 million in 2023, then sank by 52.96% to $869820.0 in 2024.
- The last three Raw Materials figures came in at $869820.0 (Q3 2024), $1.2 million (Q2 2024), and $1.7 million (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | China Pharma Holdings | 42.55 Mn | 42.24 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 869,820.00 |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 1.85 Mn |
| Sep 30, 2023 | 1.88 Mn |
| Jun 30, 2023 | 1.88 Mn |
| Mar 31, 2023 | 2.18 Mn |
| Dec 31, 2022 | 1.84 Mn |
| Sep 30, 2022 | 1.56 Mn |
| Jun 30, 2022 | 1.90 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Jun 30, 2021 | 1.76 Mn |
| Mar 31, 2021 | 1.79 Mn |
| Dec 31, 2020 | 2.08 Mn |
| Sep 30, 2020 | 2.06 Mn |
| Jun 30, 2020 | 1.80 Mn |
| Mar 31, 2020 | 1.92 Mn |
| Dec 31, 2019 | 2.11 Mn |
| Sep 30, 2019 | 2.28 Mn |